Live feed
Filing
SC 13G
SC 13G0001387131-20-004398·GSK plc
Schedule 13G ownership disclosure
Vir Biotechnology Inc
Security class unavailable · CUSIP: 92764N102
Event date: 2020-04-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,626,027
- Percent of class
- 6.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-004398
- Form type
- SC 13G
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- May 04, 2020
- Reporting period
- Apr 22, 2020
- Description
- Schedule 13G beneficial ownership